1. Home
  2. HYB vs GNFT Comparison

HYB vs GNFT Comparison

Compare HYB & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYB
  • GNFT
  • Stock Information
  • Founded
  • HYB 1987
  • GNFT 1999
  • Country
  • HYB United States
  • GNFT France
  • Employees
  • HYB N/A
  • GNFT N/A
  • Industry
  • HYB Investment Managers
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HYB Finance
  • GNFT Health Care
  • Exchange
  • HYB Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • HYB 191.2M
  • GNFT 179.7M
  • IPO Year
  • HYB 1999
  • GNFT 2019
  • Fundamental
  • Price
  • HYB $8.28
  • GNFT $3.74
  • Analyst Decision
  • HYB
  • GNFT Strong Buy
  • Analyst Count
  • HYB 0
  • GNFT 1
  • Target Price
  • HYB N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • HYB 39.6K
  • GNFT 9.9K
  • Earning Date
  • HYB 01-01-0001
  • GNFT 09-19-2024
  • Dividend Yield
  • HYB 6.67%
  • GNFT N/A
  • EPS Growth
  • HYB N/A
  • GNFT N/A
  • EPS
  • HYB N/A
  • GNFT 0.47
  • Revenue
  • HYB N/A
  • GNFT $86,225,222.00
  • Revenue This Year
  • HYB N/A
  • GNFT $145.20
  • Revenue Next Year
  • HYB N/A
  • GNFT N/A
  • P/E Ratio
  • HYB N/A
  • GNFT $7.89
  • Revenue Growth
  • HYB N/A
  • GNFT 175.45
  • 52 Week Low
  • HYB $6.23
  • GNFT $3.35
  • 52 Week High
  • HYB $7.41
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • HYB 58.20
  • GNFT 49.41
  • Support Level
  • HYB $8.21
  • GNFT $3.68
  • Resistance Level
  • HYB $8.27
  • GNFT $4.03
  • Average True Range (ATR)
  • HYB 0.06
  • GNFT 0.15
  • MACD
  • HYB 0.01
  • GNFT 0.05
  • Stochastic Oscillator
  • HYB 92.86
  • GNFT 57.35

About HYB New America High Income Fund Inc. (The)

New America High Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: